• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Medtronic

Needham & Co. downgrades Medtronic, Zimmer Biomet shares

May 27, 2022 By Chris Newmarker

Needham & Co. Senior Research Analyst Mike Matson today downgraded his rating of Medtronic (NYSE:MDT) and Zimmer Biomet (NYSE:ZBH) shares to Hold, while Boston Scientific (NYSE:BSX) got an upgrade to Buy. MDT shares were down more than 1% to $97.98 apiece in morning trading, a day after Q4 earnings that missed The Street sent the […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Orthopedics, Surgical, Wall Street Beat Tagged With: BTIG, Medtronic, Needham & Co., Truist Securities, Zimmer Biomet

‘Catastrophic explosion’ and resin shortage led Medtronic’s supply chain problems

May 26, 2022 By Jim Hammerand

Medtronic CEO Geoff Martha today said a “catastrophic explosion” in Medtronic’s supply chain for packaging and a shortage of resins were the biggest issues hurting the company’s fourth-quarter performance. Fridley, Minnesota-based Medtronic (NYSE:MDT) reported about $350 million less in sales than analysts were expecting for the quarter, which ended April 29. Martha said about 75% of […]

Filed Under: Blog, Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Outsourcing, Robotics, Surgical Tagged With: Medtronic, resin, semiconductor, supply chain

Medtronic ‘hopeful’ on FDA clearance for next-gen diabetes tech in FY 2023

May 26, 2022 By Sean Whooley

The Medtronic (NYSE:MDT) diabetes business sputtered in the fourth quarter but could be bolstered by a major regulatory nod this year. The Fridley, Minnesota-based company saw revenues for its diabetes arm fall by 7.7% year-over-year in the fourth quarter amid overall misses on both sales and adjusted earnings per share compared to Wall Street’s expectations. […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Patient Monitoring, Regulatory/Compliance, Wall Street Beat Tagged With: Medtronic

Medtronic, DaVita to form new kidney care company

May 26, 2022 By Sean Whooley

Medtronic (NYSE:MDT) and DaVita (NYSE:DVA) today announced the intent to form a new medical device company for kidney care. The new, independent company — dubbed “NewCo” for now — aims to enhance the patient treatment experience and improve overall outcomes for kidney care patients. According to a news release, the new company will bring together […]

Filed Under: Business/Financial News, Dialysis, Featured, Mergers & Acquisitions, News Well Tagged With: DaVita Inc., Medtronic

Medtronic stock down on Q4 earnings miss

May 26, 2022 By Sean Whooley

Medtronic (NYSE:MDT) shares are down today on fourth-quarter results that missed the consensus forecast. Shares of MDT were down more than 4% to $100.56 apiece in morning trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up slightly. The Fridley, Minnesota-based medtech giant posted profits of $1.5 […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Medtronic

Zimmer Biomet narrowly avoids shareholder rebuke on executive pay

May 20, 2022 By Jim Hammerand

An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54 percent of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93 […]

Filed Under: Blog, Business/Financial News, Featured, News Well, Orthopedics Tagged With: Medtronic, SEC, Zimmer Biomet, ZimVie

Study shows strong performance, improved outcomes with Medtronic Evolut TAVR

May 18, 2022 By Sean Whooley

Medtronic (NYSE:MDT) today announced positive results from a study of its Evolut transcatheter aortic valve replacement (TAVR) system. The Optimize PRO clinical study evaluated the self-expanding, supra-annular Evolut PRO and PRO+ TAVR platforms. Medtronic’s CoreValve Evolut R, CorValve Evolut PRO and Evolut Pro+ systems are indicated for the relief of aortic stenosis in patients with […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, News Well, Replacement Heart Valves, Structural Heart Tagged With: Medtronic, tavr

Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy

May 18, 2022 By Sean Whooley

Data presented today at the EuroPCR 2022 event supported the use of the Medtronic (NYSE:MDT) Resolute Onyx drug-eluting stent. University of Padua Medical School Head of Interventional Cardiology Dr. Giuseppe Tarantini presented late-breaking clinical trial results from the investigator-initiated, Medtronic-funded ROLEX (Revascularization Of LEft Main With Resolute onyX) registry. ROLEX, the largest real-world, multicenter prospective study, observed […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Drug-Device Combinations, Drug-Eluting Stents, Featured, Implants, News Well, Stents, Structural Heart, Vascular Tagged With: Medtronic

Medtronic’s renal denervation system demonstrates better blood pressure control, time in range

May 17, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced today that new data supports the use of its Symplicity Spyral renal denervation (RDN) system. As part of the medtech giant’s Spyral HTN global clinical program, three-year data from the Spyral HTN-ON MED and GSR-Define trials were presented at EuroPCR 2022 as late-breaking clinical trials demonstrating the benefit of the Symplicity blood […]

Filed Under: Blood Management, Cardiovascular, Clinical Trials, Featured, News Well Tagged With: Medtronic, renal denervation

The road to a robot: Medtronic’s development process for its Hugo RAS system

May 16, 2022 By Sean Whooley

Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Health Technology, News Well, Regulatory/Compliance, Robotics, Surgical, Urology Tagged With: Covidien, DeviceTalks Boston, Medtronic, Robotic Surgery, surgical robot

FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent

May 13, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced today that it received FDA approval for its Onyx Frontier drug-eluting stent (DES). Onyx Frontier, the latest iteration of Medtronic’s Resolute DES family, was designed to leverage the same stent platform as Resolute with an enhanced delivery system for improving deliverability and increasing acute performance, even in the most challenging of cases. Get […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Drug-Device Combinations, Drug-Eluting Stents, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Stents, Structural Heart, Vascular Tagged With: FDA, Medtronic

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 125
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS